Brookfield Asset Management Inc. Insulet Corp Transaction History

Brookfield Asset Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Sep 25, 2023	SELL	$272.48 - $330.23 $751,227 - $910,444	-2,757 Reduced 25.04%	8,252 $2.38 Million
Q2 2023 Aug 14, 2023	SELL	$272.48 - $330.23 $751,227 - $910,444	-2,757 Reduced 25.04%	8,252 $2.38 Million
Q1 2023 Sep 25, 2023	BUY	$276.36 - $326.03 $761,924 - $898,864	2,757 Added 33.41%	11,009 $3.51 Million
Q1 2023 May 15, 2023	SELL	$276.36 - $326.03 $9.04 Million - $10.7 Million	-32,717 Reduced 74.82%	11,009 $3.51 Million
Q4 2022 Feb 14, 2023	BUY	$212.22 - $313.46 $9.28 Million - $13.7 Million	43,726 New	43,726 $12.9 Million

687

62.6M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.3B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.